comparemela.com

Latest Breaking News On - Australia clinical - Page 2 : comparemela.com

백신 전철 밟나? 경구·흡입 치료제 선구매 서둘러야

백신 전철 밟나? 경구·흡입 치료제 선구매 서둘러야
fnnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fnnews.com Daily Mail and Mail on Sunday newspapers.

Australia
Japan
United-states
South-korea
Incheon-yeonsugu-celltrion
Development-success
United-states-development
Australia-clinical
Guro-hospital

셀트리온, 흡입형 코로나19 치료제 본격 개발.. 호주 임상 1상 승인

셀트리온, 흡입형 코로나19 치료제 본격 개발.. 호주 임상 1상 승인
kbench.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kbench.com Daily Mail and Mail on Sunday newspapers.

Australia
United-states
Safety-division
Australia-clinical
셀트리온
ஆஸ்திரேலியா
ஒன்றுபட்டது-மாநிலங்களில்
பாதுகாப்பு-பிரிவு

셀트리온 렉키로나, 델타 변이 동물시험서 효능 확인

셀트리온 렉키로나, 델타 변이 동물시험서 효능 확인
zdnet.co.kr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from zdnet.co.kr Daily Mail and Mail on Sunday newspapers.

Australia
United-states
America
United-states-biology
South-america
Europe-clinical
Australia-clinical
ஆஸ்திரேலியா
ஒன்றுபட்டது-மாநிலங்களில்
அமெரிக்கா
ஒன்றுபட்டது-மாநிலங்களில்-உயிரியல்

솔젠트 놓친 EDGC, 관계사 항암제 개발 띄우며 안간힘

bar progress 솔젠트 놓친 EDGC, 관계사 항암제 개발 띄우며 안간힘 검색 등록 2021.07.08 08:05 바이로큐어 임상성과 홍보···솔젠트 진단키트 때와 ‘기시감’ 지난해 고점 대비 반토막난 주가···“본업 실적개선 주력해야” 호재에도 미지근한 시장 반응···증권가는 건기식 판매 기대 솔젠트의 경영권을 잃은 EDGC가 이번엔 관계사 바이로큐어의 항암제를 띄우며 안간힘을 쓰고 있다. 앞서 솔젠트의 진단키트를

China
Australia
United-states
Dankook-university
Australia-clinical
Business-report
Clinical-step
Big-data
சீனா
ஆஸ்திரேலியா
ஒன்றுபட்டது-மாநிலங்களில்

에이비온, '동반진단-항암제'로 코스닥행 3수 도전

에이비온, '동반진단-항암제'로 코스닥행 3수 도전
edaily.co.kr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from edaily.co.kr Daily Mail and Mail on Sunday newspapers.

Seoul
Soult-ukpyolsi
South-korea
Australia
Japan
United-states
Korea
Samsung
Seoul-national-university
Drug-administration
Seoul-national-university-college-of-pharmacy
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.